EFLUELDA susp inj 2024/2025 ser pré 0.7 ml
7680677040221
CH-67704
J07BB02
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Efluelda 0.7 ml, suspension injectable en seringue préremplie
suspension
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
haemagglutininum influenzae A (H1N1)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae A (H3N2)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae B
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae B
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
natrii chloridum
|
- | Substance | HNIDK |
|
dinatrii phosphas
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas anhydricus
|
- | Substance | HNIDK |
|
octoxinolum-9
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
2.72 MG | Substance | HBESI |
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 67704
- Drug name
- Efluelda Tetra, suspension injectable en seringue préremplie
- Galenic form
- INJFS
- ATC Code
- J07BB02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 21/07/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EFLUELDA susp inj 2024/2025 ser pré 0.7 ml
- Description (DE)
- EFLUELDA Inj Susp 2024/2025 Fertspr 0.7 ml
- Market launch
- 16/08/2024
- Narcotic (BTM)
- No